Nanopath

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of a molecular diagnostic platform designed to enable point-of-care disease diagnosis. Nanopath is based in Cambridge, MA and was founded in 2019. It was valued at $32 million at its early-stage round in Aug 2022, the last priced event on record. It has raised $16.4 million across 2 recorded rounds; the latest was a $5.3 million debt round in Jan 2025.

PMV mark · valuation
$32.0M
Oct 2026
Priced at
its early-stage round
Aug 2022
Total raised
$16.4M
Last round
Debt
Jan 2025
Cap table — not yet on record

Nanopath's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nanopath with a free account
  • ·The complete investor list: 17 names
  • ·Watch Nanopath: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Nanopath

Where does Nanopath's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Nanopath's 2 recorded funding rounds.